End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
105.1 INR | -5.99% |
|
+6.32% | 0.00% |
Income Statement Evolution (Annual data)
Fiscal Period: März | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net sales 1 | 424.6 | 201.6 | 326.8 | 317.9 |
EBITDA 1 | 29.4 | -4.26 | 8.879 | 54.01 |
EBIT 1 | 24.48 | -7.674 | 6.102 | 50.62 |
Operating Margin | 5.76% | -3.81% | 1.87% | 15.92% |
Earnings before Tax (EBT) 1 | 18.15 | 4.783 | 8.108 | 60.55 |
Net income 1 | 13.02 | 3.536 | 6.141 | 44.82 |
Net margin | 3.07% | 1.75% | 1.88% | 14.1% |
EPS 2 | 0.2600 | 0.2200 | 0.3600 | 2.700 |
Free Cash Flow | - | -39.98 | 45.57 | 82.28 |
FCF margin | - | -19.83% | 13.94% | 25.88% |
FCF Conversion (EBITDA) | - | - | 513.21% | 152.33% |
FCF Conversion (Net income) | - | - | 741.99% | 183.58% |
Dividend per Share | - | - | - | - |
Announcement Date | 11/2/21 | 11/2/21 | 9/5/22 | 11/25/23 |
Balance Sheet Analysis
Fiscal Period: März | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net Debt 1 | - | 11.6 | - | 11 |
Net Cash position 1 | 12.9 | - | 3.97 | - |
Leverage (Debt/EBITDA) | - | -2.726 x | - | 0.204 x |
Free Cash Flow | - | -40 | 45.6 | 82.3 |
ROE (net income / shareholders' equity) | - | 1.39% | 2.38% | 15.5% |
ROA (Net income/ Total Assets) | - | -1.11% | 0.93% | 6.75% |
Assets 1 | - | -317.6 | 661.2 | 663.7 |
Book Value Per Share 2 | 23.50 | 15.40 | 15.80 | 18.80 |
Cash Flow per Share 2 | 6.080 | 1.730 | 1.720 | 1.350 |
Capex 1 | 1.09 | 1.82 | - | 15.9 |
Capex / Sales | 0.26% | 0.9% | - | 5% |
Announcement Date | 11/2/21 | 11/2/21 | 9/5/22 | 11/25/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
0.00% | 30.45M | |
+9.37% | 6.53B | |
-39.47% | 1.31B | |
-16.04% | 1.15B | |
-28.73% | 952M | |
-16.21% | 486M | |
+25.19% | 463M | |
+10.39% | 429M | |
-48.21% | 394M | |
-36.84% | 347M |
- Stock Market
- Equities
- MAXPOSURE Stock
- Financials Maxposure Limited